Studies have found that luteolin, in combination with zinc oxide (ZnO) nanoparticles, may alleviate NAFLD by reducing insulin resistance, improving oxidative stress, and modulating insulin signaling [41]. The gene discussed is INS; the disease is metabolic dysfunction-associated steatotic liver disease.